niacinamide has been researched along with Gastrointestinal Hemorrhage in 9 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Gastrointestinal Hemorrhage: Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib, an oral inhibitor of multiple tyrosine kinase receptors, has been widely used as a standard medical treatment for advanced hepatocellular carcinoma (HCC)." | 7.81 | Radiation-induced hemorrhagic duodenitis associated with sorafenib treatment. ( Azuma, K; Esaki, M; Kitazono, T; Matsumoto, T; Nakamura, S; Ooho, A; Yanai, S, 2015) |
| "The purpose of the present study was to compare the efficacies of transarterial chemoembolization (TACE) combined with sorafenib versus TACE monotherapy for treating patients with advanced hepatocellular carcinoma (HCC)." | 7.80 | Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study. ( Duan, Z; Hertzanu, Y; Hu, H; Liu, S; Long, X; Shi, H; Yang, Z, 2014) |
| "A 60-year-old man with liver cirrhosis caused by hepatitis C, who was receiving warfarin anticoagulation following acute myocardial infarction, was diagnosed with advanced hepatocellular carcinoma and multiple lung metastases, and began treatment with sorafenib 200 mg daily." | 7.77 | [Gastrointestinal hemorrhage associated with concurrent use of sorafenib and warfarin for hepatocellular carcinoma]. ( Hara, F; Hirano, N; Iida, K; Ishii, K; Kikuchi, Y; Shiozawa, K; Sumino, Y; Wakui, N; Watanabe, M, 2011) |
| "Sorafenib, an oral inhibitor of multiple tyrosine kinase receptors, has been widely used as a standard medical treatment for advanced hepatocellular carcinoma (HCC)." | 3.81 | Radiation-induced hemorrhagic duodenitis associated with sorafenib treatment. ( Azuma, K; Esaki, M; Kitazono, T; Matsumoto, T; Nakamura, S; Ooho, A; Yanai, S, 2015) |
| "The purpose of the present study was to compare the efficacies of transarterial chemoembolization (TACE) combined with sorafenib versus TACE monotherapy for treating patients with advanced hepatocellular carcinoma (HCC)." | 3.80 | Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study. ( Duan, Z; Hertzanu, Y; Hu, H; Liu, S; Long, X; Shi, H; Yang, Z, 2014) |
| "A 60-year-old man with liver cirrhosis caused by hepatitis C, who was receiving warfarin anticoagulation following acute myocardial infarction, was diagnosed with advanced hepatocellular carcinoma and multiple lung metastases, and began treatment with sorafenib 200 mg daily." | 3.77 | [Gastrointestinal hemorrhage associated with concurrent use of sorafenib and warfarin for hepatocellular carcinoma]. ( Hara, F; Hirano, N; Iida, K; Ishii, K; Kikuchi, Y; Shiozawa, K; Sumino, Y; Wakui, N; Watanabe, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, YH | 1 |
| Kim, MJ | 1 |
| Choe, SW | 1 |
| Sprecher, D | 1 |
| Lee, YJ | 1 |
| P Oh, S | 1 |
| Takahashi, Y | 1 |
| Fukunishi, S | 1 |
| Nishikawa, T | 1 |
| Nouda, S | 1 |
| Sasaki, Y | 1 |
| Sanomura, M | 1 |
| Umegaki, E | 1 |
| Higuchi, K | 1 |
| Hu, H | 1 |
| Duan, Z | 1 |
| Long, X | 1 |
| Hertzanu, Y | 1 |
| Shi, H | 1 |
| Liu, S | 1 |
| Yang, Z | 1 |
| Yanai, S | 1 |
| Nakamura, S | 2 |
| Ooho, A | 1 |
| Esaki, M | 1 |
| Azuma, K | 1 |
| Kitazono, T | 1 |
| Matsumoto, T | 1 |
| Wu, SS | 1 |
| Yen, HH | 1 |
| Chung, CY | 1 |
| Mancuso, A | 1 |
| Airoldi, A | 1 |
| Vigano, R | 1 |
| Pinzello, G | 1 |
| Lucas, E | 1 |
| Aubourg, A | 1 |
| Bacq, Y | 1 |
| Perarnau, JM | 1 |
| Shiozawa, K | 1 |
| Watanabe, M | 1 |
| Hirano, N | 1 |
| Wakui, N | 1 |
| Kikuchi, Y | 1 |
| Hara, F | 1 |
| Ishii, K | 1 |
| Iida, K | 1 |
| Sumino, Y | 1 |
| Neubert, D | 1 |
| Zens, P | 1 |
| Rothenwallner, A | 1 |
| Merker, HJ | 1 |
9 other studies available for niacinamide and Gastrointestinal Hemorrhage
| Article | Year |
|---|---|
Selective effects of oral antiangiogenic tyrosine kinase inhibitors on an animal model of hereditary hemorrhagic telangiectasia.
Topics: Activin Receptors, Type I; Activin Receptors, Type II; Administration, Oral; Administration, Topical | 2017 |
Small-intestinal hemorrhage caused by treatment with sorafenib for hepatocellular carcinoma and diagnosed by capsule endoscopy.
Topics: Aged, 80 and over; Antineoplastic Agents; Capsule Endoscopy; Carcinoma, Hepatocellular; Female; Gast | 2013 |
Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Mod | 2014 |
Radiation-induced hemorrhagic duodenitis associated with sorafenib treatment.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Duodenitis; Gastrointestinal Hemorrhage; Humans; L | 2015 |
Oesophageal variceal bleeding in hepatocellular carcinoma with portal vein thrombosis: improved outcome in response to molecular target therapy.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; | 2008 |
Fatal gastric bleeding during sorafenib treatment for hepatocellular carcinoma recurrence after liver transplantation.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Fatal Outcome; Gastrointestinal | 2011 |
Coil extrusion from a gastric varice during sorafenib treatment for hepatocellular carcinoma.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; | 2011 |
[Gastrointestinal hemorrhage associated with concurrent use of sorafenib and warfarin for hepatocellular carcinoma].
Topics: Anticoagulants; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Drug Therapy, C | 2011 |
A survey of the embryotoxic effects of TCDD in mammalian species.
Topics: 2,4,5-Trichlorophenoxyacetic Acid; Abnormalities, Drug-Induced; Amines; Animals; Cleft Palate; Cyclo | 1973 |